| Dr Jacqueline Geneva Curtis, MD | |
|
3901 Arlington Highlands Blvd, Ste 200, Arlington, TX 76018-6036 | |
| (817) 719-3736 | |
| Not Available |
| Full Name | Dr Jacqueline Geneva Curtis |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 3901 Arlington Highlands Blvd, Arlington, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255697660 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | Q8040 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jacqueline Geneva Curtis, MD 3901 Arlington Highlands Blvd, Ste 200, Arlington, TX 76018-6036 Ph: (817) 719-3736 | Dr Jacqueline Geneva Curtis, MD 3901 Arlington Highlands Blvd, Ste 200, Arlington, TX 76018-6036 Ph: (817) 719-3736 |
News Archive
Results from a study presented today at The International Liver Congress 2015 demonstrate that the use of a pocket-sized ultrasound device (PUD) helps to reduce the need for further testing in both the inpatient and outpatient setting.
Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to researchers at The University of Texas Health Science Center at Houston.
Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
Aduro BioTech, a clinical-stage immunotherapy company, announced today the issuance of two important patents, the formation of a distinguished scientific advisory board, the addition of key members to its Board of Directors, and the reporting of preliminary top line long-term survival data from a Phase 1 clinical trial with 2 year follow-up.
A small study in the British Medical Journal suggests a new human genotype may be prone to variant Creutzfeldt-Jakob disease (vCJD).
› Verified 5 days ago
John R Marshall, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1107 N Cooper St, Arlington, TX 76011 Phone: 817-860-6067 Fax: 817-860-6016 | |
Dr. Annette Marie Shelton, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2011 E Lamar Blvd Ste 100, Arlington, TX 76006 Phone: 817-548-0504 Fax: 817-861-8845 | |
Mr. Sajish Eapen Jacob, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 811 W Interstate 20 Ste 224, Arlington, TX 76017 Phone: 817-641-6000 Fax: 817-419-4501 | |
Dr. Rajendra P Gandhi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 912 Wright St, Suite B, Arlington, TX 76012 Phone: 817-274-7593 Fax: 817-261-4785 | |
Dr. Sylvia Arlene Moring, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1715 Venetian Cir, Arlington, TX 76013 Phone: 817-795-7222 | |
Dr. Robert Charles Knipstein, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 731 N Fielder, Suite 100, Arlington, TX 76012 Phone: 817-265-2021 Fax: 817-265-3410 |